We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · March 11, 2021

Obeticholic Acid Use in Patients With Primary Biliary Cholangitis and Suboptimal Response to Ursodeoxycholic Acid

Alimentary Pharmacology & Therapeutics

 

Additional Info

Disclosure statements are available on the authors' profiles:

Alimentary Pharmacology & Therapeutics
Effectiveness and Safety of Obeticholic Acid in a Southern European Multicenter Cohort of Patients With Primary Biliary Cholangitis and Suboptimal Response to Ursodeoxycholic Acid
Aliment. Pharmacol. Ther. 2021 Feb 01;53(4)519-530, E Gomez, L Garcia Buey, E Molina, M Casado, I Conde, M Berenguer, F Jorquera, MA Simón, A Olveira, M Hernández-Guerra, M Mesquita, J Presa, P Costa-Moreira, G Macedo, JI Arenas, J Manuel Sousa, J Ampuero, RM Morillas, A Santos, A De Carvalho, J Uriz, JA Carrión, M Luisa Gutiérrez, E Pérez-Fernández, CM Fernández-Rodríguez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading